title: Enkephalin degradating enzymes in pheochromocytoma patients.
abstract: Adrenal gland as a major source of enkephalins on the periphery can be affected by a rare adrenal gland tumor, adrenal pheochromocytoma. It has been demonstrated that this tumor might be associated with altered concentration of enkephalin-like peptides. The effect of these peptides can be either prolonged or abbreviated by two neutrophil membrane bound enzymes; aminopeptidase N (APN) and neutral endopeptidase (NEP). We assumed that altered enkephalin level in pheochromocytoma patients (but not in patients with non-functional adenomas or tumors of different origin) might result in differently regulated APN and/or NEP activity. We measured APN and NEP activity on surface of neutrophils, level of lipid peroxidation (LPO) in plasma and enkephalin concentration in plasma in patients with pheochromocytomas, non-functional adenomas, malignant renal tumors and healthy controls. Catheholamines and vanyllmandelic acid (VMA) were measured in 24-h urine of pheochromocytoma patients. NEP and APN activity on neutrophils from all pheochromocytoma patients was significantly increased as compared with healthy controls, non-functional adenomas and malignant renal tumors. In all pheochromocytoma patients NEP activity was reduced almost to the control level after surgery. At the same time APN activity was in some patients up- and in others down-regulated. In comparison, elevated levels of cateholamines and VMA were found after multiple determinations in 6 out of 10 pheochromocytoma patients. Although preliminary, this study has shown specifically and consistently up-regulated NEP activity on neutrophils from pheochromocytoma patients, and uniformly decreased NEP activity in these patients after adrenalectomy.
authors.affiliation: Institute Ruder Boskovic, Department of Molecular Medicine, University of Zagreb, Croatia. balog@rudjer.irb.hr
authors.forename: Tihomir
authors.initials: T
authors.lastname: Balog
authors.forename: Tatjana
authors.initials: T
authors.lastname: Marotti
authors.forename: Visnja
authors.initials: V
authors.lastname: Sverko
authors.forename: Miljenko
authors.initials: M
authors.lastname: Marotti
authors.forename: Ivan
authors.initials: I
authors.lastname: Krolo
authors.forename: Boris
authors.initials: B
authors.lastname: Rocic
authors.forename: Nikola
authors.initials: N
authors.lastname: Karapanda
mesh_terms: D000236:Adenoma / Q000201:enzymology / Q000473:pathology; D000310:Adrenal Gland Neoplasms / Q000201:enzymology* / Q000473:pathology; D018826:CD13 Antigens / Q000097:blood*; D016022:Case-Control Studies; D002395:Catecholamines / Q000652:urine; D015536:Down-Regulation; D004744:Enkephalin, Methionine / Q000097:blood; D004745:Enkephalins / Q000097:blood*; D006801:Humans; D015227:Lipid Peroxidation; D015260:Neprilysin / Q000097:blood*; D009504:Neutrophils / Q000378:metabolism; D010673:Pheochromocytoma / Q000201:enzymology* / Q000473:pathology; D017392:Thiobarbituric Acid Reactive Substances / Q000378:metabolism; D015854:Up-Regulation
chemical_list: D002395:Catecholamines; D004745:Enkephalins; D017392:Thiobarbituric Acid Reactive Substances; D004744:Enkephalin, Methionine; D018826:CD13 Antigens; D015260:Neprilysin